Beta thalassemia - a review
<p>Thalassemia is a globin gene disorder that results in a diminished rate of synthesis of one or more of the globin chains. About 1.5% of the global population (80 to 90 million people) are carriers of beta Thalassemia. More than 200 mutations are described in beta thalassemia. However not al...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Book |
| Published: |
Association of Clinical Pathologists of Nepal,
2014-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | <p>Thalassemia is a globin gene disorder that results in a diminished rate of synthesis of one or more of the globin chains. About 1.5% of the global population (80 to 90 million people) are carriers of beta Thalassemia. More than 200 mutations are described in beta thalassemia. However not all mutations are common in different ethnic groups. The only effective way to reduce burden of thalassemia is to prevent birth of homozygotes. Diagnosis of beta thalassemia can be done by fetal DNA analysis for molecular defects of beta thalassemia or by fetal blood analysis. Hematopoietic stem cell transplantation is the only available curative approach for Thalassemia. Many patients with thalassemia in underdeveloped nations die in childhood or adolescence. Programs that provide acceptable care, including transfusion of safe blood and supportive therapy including chelation must be established.</p><p>DOI: <a href="http://dx.doi.org/10.3126/jpn.v4i8.11609">http://dx.doi.org/10.3126/jpn.v4i8.11609</a></p> <p>Journal of Pathology of Nepal; Vol.4,No. 8 (2014) 663-671</p> |
|---|---|
| Item Description: | 2091-0797 2091-0908 10.3126/jpn.v4i8.11609 |